Elos Medtech Nomination Committee appointed for the 2023 Annual General Meeting

In accordance with the decision of the 2022 Annual General Meeting the Nomination Committee shall consist of not less than three and not more than five members. In addition, the Chairman of the Board shall be co-opted to the Nomination Committee. Based on the shareholder statistics on 31 August 2022 kept by Euroclear, the Chairman of the Board will offer the three largest shareholders based on the largest voting rights, as well as the shareholder with the largest proportion of equity to appoint members to the Nomination Committee. If the same shareholder is both among the three largest in voting rights and the largest in the capital share, representation takes place only with one participant from the same shareholder, while the shareholder who comes closest in succession to the capital share is offered to be represented in the Nomination Committee. If shareholders waive the right to appoint a member within one week of being contacted by the Chairman of the Board, the right to appoint a member transfer to a shareholder who, in the number of votes and the capital share respectively, comes closest in succession. Called members as above have undertaken to represent the respective shareholders, which has taken place within a week.

In accordance with the decision of the Annual General Meeting of Elos Medtech AB, the following has been appointed a member of the Nomination Committee:

• Lovisa Lander, appointed by EM Intressenter AB (TA Associates)
• Thomas Öster, appointed by family Öster (incl. companies)
• Kent Molin, appointed by family Molin
• Jonas Fridh, appointed by Bank Julius Baer & Co LTD

The Chairman of the Nomination Committee is Lovisa Lander, appointed by the Nomination Committee. The Chairman of the Board, Magnus René, is co-opted to the Nomination Committee.

As of 31 August 2022, the Nomination Committee together represents approximately 97 percent of the voting rights for all voting shares in the company.

The Annual General Meeting of Elos Medtech AB will be held on Wednesday, 3 May 2023.

The Nomination Committee shall submit proposals on the following issues for resolution to the 2023 Annual General Meeting:

• Election of Chairman of the meeting
• Number of board members
• Remuneration to the Board of Directors and Chairman of the Board and remuneration for committee work
• Election of members and Chairman of the Board
• Fees to auditor
• Election of auditor
• Tasks and principles of the Nomination Committee

The Nomination Committee's proposal will be presented in the notice convening the Annual General Meeting 2023 and on the company's website.

Shareholders who wish to submit proposals to Elos Medtech's Nomination Committee can send an e-mail to valberedning@elosmedtech.com with the title ”To the Nomination Committee” or by mail to Elos Medtech AB, Torsgatan 5B, SE-411 04 Gothenburg, marked ”To the Nomination Committee” at the latest 20 January, 2023.

Gothenburg, October 14, 2022

Elos Medtech AB (publ)

For more information, please contact Lovisa Lander, Chairman of The Nomination Committee,
phone: +44 (0)20 7823 0211 e-mail: llander@ta.com

For additional information about the Elos Medtech Group, visit www.elosmedtech.com

Tags: